Aethlon Medical (AEMD) Debt to Equity (2011 - 2023)

Aethlon Medical's Debt to Equity history runs 13 years deep, the most recent figure standing at $0.01 for Q1 2023.

• For the quarter ending Q1 2023, Debt to Equity rose 55.15% year-over-year to $0.01; the trailing twelve-month figure through Mar 2023 stood at $0.01 (up 55.15% YoY), and the FY2023 full-year result was $0.01, up 55.15% from the prior year.
• Debt to Equity was $0.01 for Q1 2023 at Aethlon Medical, up from $0.01 in the prior quarter.
• Over the last five years, Debt to Equity for AEMD reached as high as $4.91 in Q3 2019 and fell as low as $0.0 in Q2 2021.
• Median Debt to Equity over the past 5 years was $0.01 (2020), compared with a mean of $0.31.
• Across the five-year window, Debt to Equity surged 19815.5% in 2019 and tumbled 99.76% in 2020, its largest moves.
• Over 5 years, Debt to Equity stood at $0.03 in 2019, then plunged by 60.59% to $0.01 in 2020, then slumped by 44.96% to $0.01 in 2021, then jumped by 73.76% to $0.01 in 2022, then grew by 29.06% to $0.01 in 2023.
• Business Quant data shows AEMD's Debt to Equity at $0.01 in Q1 2023, $0.01 in Q4 2022, and $0.01 in Q3 2022.